245 related articles for article (PubMed ID: 18644386)
1. Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control.
Bhunu CP; Garira W; Mukandavire Z; Magombedze G
J Theor Biol; 2008 Oct; 254(3):633-49. PubMed ID: 18644386
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis transmission model with chemoprophylaxis and treatment.
Bhunu CP; Garira W; Mukandavire Z; Zimba M
Bull Math Biol; 2008 May; 70(4):1163-91. PubMed ID: 18231839
[TBL] [Abstract][Full Text] [Related]
3. Potential impact of tuberculosis vaccines as epidemic control agents.
Lietman T; Blower SM
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S316-22. PubMed ID: 10875909
[TBL] [Abstract][Full Text] [Related]
4. Implications of partial immunity on the prospects for tuberculosis control by post-exposure interventions.
Gabriela M Gomes M; Rodrigues P; Hilker FM; Mantilla-Beniers NB; Muehlen M; Cristina Paulo A; Medley GF
J Theor Biol; 2007 Oct; 248(4):608-17. PubMed ID: 17669435
[TBL] [Abstract][Full Text] [Related]
5. Theoretical assessment of public health impact of imperfect prophylactic HIV-1 vaccines with therapeutic benefits.
Elbasha EH; Gumel AB
Bull Math Biol; 2006 Apr; 68(3):577-614. PubMed ID: 16794946
[TBL] [Abstract][Full Text] [Related]
6. Safety issues regarding new vaccines for tuberculosis, with an emphasis on post-exposure vaccination.
Orme IM
Tuberculosis (Edinb); 2006 Jan; 86(1):68-73. PubMed ID: 16260181
[TBL] [Abstract][Full Text] [Related]
7. Backward bifurcations in dengue transmission dynamics.
Garba SM; Gumel AB; Abu Bakar MR
Math Biosci; 2008 Sep; 215(1):11-25. PubMed ID: 18573507
[TBL] [Abstract][Full Text] [Related]
8. Mathematical analysis of a two strain HIV/AIDS model with antiretroviral treatment.
Bhunu CP; Garira W; Magombedze G
Acta Biotheor; 2009 Sep; 57(3):361-81. PubMed ID: 19357968
[TBL] [Abstract][Full Text] [Related]
9. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL
Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis: vaccines in the pipeline.
Ly LH; McMurray DN
Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
[TBL] [Abstract][Full Text] [Related]
11. Analysis of SIR epidemic models with nonlinear incidence rate and treatment.
Hu Z; Ma W; Ruan S
Math Biosci; 2012 Jul; 238(1):12-20. PubMed ID: 22516532
[TBL] [Abstract][Full Text] [Related]
12. Role of incidence function in vaccine-induced backward bifurcation in some HIV models.
Sharomi O; Podder CN; Gumel AB; Elbasha EH; Watmough J
Math Biosci; 2007 Dec; 210(2):436-63. PubMed ID: 17707441
[TBL] [Abstract][Full Text] [Related]
13. A theoretical assessment of the effects of smoking on the transmission dynamics of tuberculosis.
Bhunu CP; Mushayabasa S; Tchuenche JM
Bull Math Biol; 2011 Jun; 73(6):1333-57. PubMed ID: 20725798
[TBL] [Abstract][Full Text] [Related]
14. Decentralized resource allocation to control an epidemic: a game theoretic approach.
Wang S; de Véricourt F; Sun P
Math Biosci; 2009 Nov; 222(1):1-12. PubMed ID: 19683014
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
Dietrich J; Doherty TM
APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
17. Is intranasal vaccination a feasible solution for tuberculosis?
Giri PK; Khuller GK
Expert Rev Vaccines; 2008 Nov; 7(9):1341-56. PubMed ID: 18980538
[TBL] [Abstract][Full Text] [Related]
18. [Preventive and therapeutic approach to tuberculosis in the general, and high-risk populations].
Spiridigliozzi S; Abetti P; Bossi A; Ruiu M; Capozza G; Monaco E
Clin Ter; 2002; 153(5):335-42. PubMed ID: 12510419
[TBL] [Abstract][Full Text] [Related]
19. Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not.
Rook GA; Dheda K; Zumla A
Tuberculosis (Edinb); 2006; 86(3-4):152-62. PubMed ID: 16510309
[TBL] [Abstract][Full Text] [Related]
20. A model for influenza with vaccination and antiviral treatment.
Arino J; Brauer F; van den Driessche P; Watmough J; Wu J
J Theor Biol; 2008 Jul; 253(1):118-30. PubMed ID: 18402981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
